3-methoxy-4-hydroxyphenylethanol has been researched along with Depression in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anokhina, IP; Gamaleia, NB | 1 |
| Friedman, E; Gershon, S; Goldstein, M; Shopsin, B; Wilk, S | 1 |
1 trial(s) available for 3-methoxy-4-hydroxyphenylethanol and Depression
| Article | Year |
|---|---|
Use of synthesis inhibitors in defining a role for biogenic amines during imipramine treatment in depressed patients.
Topics: 3-Methoxy-4-hydroxyphenylethanol; Adult; Antimetabolites; Biogenic Amines; Clinical Trials as Topic; Depression; Female; Fenclonine; Humans; Imipramine; Male; Methyltyrosines; Middle Aged; Norepinephrine; Psychiatric Status Rating Scales; Time Factors | 1975 |
1 other study(ies) available for 3-methoxy-4-hydroxyphenylethanol and Depression
| Article | Year |
|---|---|
[Current biochemical conceptions of mental diseases. II. Role of changes in the biogenic amine system in the pathogenesis of affective disorders].
Topics: 3-Methoxy-4-hydroxyphenylethanol; Affective Disorders, Psychotic; Antidepressive Agents, Tricyclic; Biogenic Amines; Bipolar Disorder; Brain; Catechol O-Methyltransferase; Cyclic AMP; Depression; Dopamine; Dopamine beta-Hydroxylase; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Kynurenine; Monoamine Oxidase Inhibitors; Norepinephrine; Receptors, Dopamine; Reserpine; Serotonin; Tryptophan | 1980 |